2,3-bis(3'-hydroxybenzyl)butyrolactone and Lung Neoplasms

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borowicz, P; Chikara, S; Christofidou-Solomidou, M; Lindsey, K; Reindl, KM	1

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Lung Neoplasms

Article	Year
Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines. BMC complementary and alternative medicine, 2017, Jan-09, Volume: 17, Issue:1 Topics: 4-Butyrolactone; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cytoskeleton; Flax; Focal Adhesion Kinase 1; Humans; Lignans; Lung Neoplasms; Phosphorylation; Plant Extracts; Signal Transduction; src-Family Kinases	2017

Article

Year

Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.

BMC complementary and alternative medicine, 2017, Jan-09, Volume: 17, Issue:1

Topics: 4-Butyrolactone; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cytoskeleton; Flax; Focal Adhesion Kinase 1; Humans; Lignans; Lung Neoplasms; Phosphorylation; Plant Extracts; Signal Transduction; src-Family Kinases

2017